Did you mean
van den quick, k

Search results - 70 results

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx

Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; Massen, Isolde Van der; De Keersmaecker, Sven; Debie, Yana; Huizing, Manon; Pannus, Pieter; Neven, Kristof Y.; Ariën, Kevin K.; Martens, Geert A.; Bulcke, Marc ...

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Publication Type: Peer reviewed scientific article Authors: J Thouvenin; C Van Marcke; L Decoster; Gordana Raicevic; K Punie; Marc Van den Bulcke; R Salgado; Els Van Valckenborgh; B Maes; S Joris; ...

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.

Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

Mebis; A. Rutten; C. Fontaine; W. Lybaert; S. Aspeslagh; J.-C. Goeminne; H. Van Den Bulck; E. Seront; L. De Backer; W. De Roock; M. Ignatiadis; H. Prenen; Dominique Van Beckhoven; M. Heijlen; J. Verheezen; ...

Precision cancer medicine: What has translated into clinical use in Belgium?

Publication Type: Conference Paper Authors: Marie Delnord; Els Van Valckenborgh; Aline Hébrant; Aline Antoniou; Wannes Van Hoof; Anouk Waeytens; Marc Van den Bulcke Source: Seminars in Cancer ...

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.

Francotte; Marc Van den Bulcke; Maan Zrein; Steven Van Gucht; Marie-Noëlle Schmickler; Mathieu Verbrugghe; André Matagne; Isabelle Thomas; Katelijne Dierick; Joshua A Weiner; Margaret E Ackerman; Stanislas ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

Y Debie; M Huizing; Pieter Pannus; K Neven; K K Ariën; G. A. Martens; Marc Van den Bulcke; E Roelant; I Desombere; S Anguille; Maria Goossens; T Vandamme; P van Dam Source: ESMO Open, Volume 6, Issue ...

The Belgian practice and attitudes towards introducing genomics in clinical oncology

Publication Type: Peer reviewed scientific article Authors: Marc Van den Bulcke; Wannes Van Hoof; Els Van Valckenborgh; Aline Hébrant; Gordana Rajcevic; Kristof Van Assche Source: Belgian journal of ...

Precision cancer medicine: What has translated into clinical use in Belgium?

Publication Type: Peer reviewed scientific article Authors: Marie Delnord; Els Van Valckenborgh; Aline Hébrant; Aline Antoniou; Wannes Van Hoof; Anouk Waeytens; Marc Van den Bulcke Source: Semin ...

Towards a European health research and innovation cloud (HRIC)

O. Riess; H. Riper; J. Roca; P. Rosenstiel; P. Sabatier; F. Sanz; M. Tayeb; G. Thomassen; Johan Van Bussel; Marc Van den Bulcke; Herman Van Oyen Source: Genome Medicine, Volume 12, Issue 1 (2020) ...

QR code

QR code for this page URL